MDA training for Israeli-Arab sector
Israel’s emergency services Magen David Adom has completed its first training course for 15 young medics who will provide emergency response to Eastern Jerusalem. The medics are bilingual in Hebrew and Arabic. The program was the initiative of Ziad Jadla, MDA’s Arab liaison.
Exercise to cure fatty liver disease
Nonalcoholic steatohepatitis (NASH) commonly known as “fatty liver disease” is the most common liver condition in the Western world. A study by Israeli doctors showed that 40 minutes resistance training, three times a week for three months reduced liver-fat and cholesterol significantly.
An app to detect ADHD
Researchers at IBM Israel have developed a prototype app that can detect attention deficit hyperactivity disorder (ADHD) symptoms. Subjects trace an imaginary rectangle ten times and the app analyzes the hand movements. ADHD sufferers have difficulty with continuous motor activity.
Link between Leukemia and HIV
Researchers at Ben-Gurion University of the Negev (BGU) have discovered similarities between Leukemia and HIV. Dr. Ran Taube is convinced that his team’s discovery is key to finding a clinical solution that can prevent infection with HIV and destroy the deadly virus.
Calming autistic children
Israel’s Association for Children at Risk has developed an Autism and Resiliency Program aimed at soothing frayed nerves of the 1,000 Israeli children with autism spectrum disorder (ASD). The program relieved trauma during Operation Protective Edge but is now being adapted to everyday needs.
Two Israelis in prestigious MIT list
Two Israelis have made MIT's prestigious "35 Innovators Under 35" list for 2015. Cigall Kadoch, 30, holds a doctorate from Stanford where her expertise is cancer research. Gilad Evrony, 33, from Harvard Medical School, made a major discovery advancing research into brain disorders.
Restoring eyesight in Kyrgyzstan
A group of Israeli doctors restored the eyesight of 90 adults and children in Kyrgyzstan thanks to Israeli-Jewish Eye from Zion volunteer organization. The doctors performed cornea surgery, plastic surgery and removed tumors and cataracts. Many patients had been blind for years.
Treatment slows onset of Alzheimer’s
Israel’s Avraham Pharmaceuticals announced successful interim results in a Phase 2b clinical trial of ladostigil, for the treatment of mild cognitive impairment (MCI). Fewer MCI patients using ladostigil for 2 years progressed to Alzheimer’s than those using the placebo.
Detecting lung cancer mutations in the genes
Israel’s Rosetta Genomics has just had approval from the New Jersey Department of Health, for its OncoGxSelect diagnostic test for lung cancer. The test detects genetic mutations responsible for the tumors and help clinicians make relevant treatment decisions.
A device to treat Peripheral Artery Disease
Israel's Eximo has developed a patented hybrid catheter, which is connected to a pulsed laser system, for the treatment of blocked arteries associated with Peripheral Artery Disease (PAD). PAD affects 8-12 million Americans. Eximo has just received $1.6 million of funding.